Top Clinical Trials companies in Australia by Capital Expenditure
Australia
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD -1.26 B
|
June 30, 2024 | USD 171.50 | 0.95% |
|
Australia |
|
| 2 |
USD -13.88 M
|
June 30, 2024 | USD 0.74 | 0.02% |
|
Australia |
|
| 3 |
USD -7.35 M
|
Dec. 31, 2023 | USD 18.31 | -0.05% |
|
Australia |
|
| 4 |
USD -4.34 M
|
June 30, 2024 | USD 2.33 | 0.29% |
|
Australia |
|
| 5 |
USD -3.72 M
|
June 30, 2024 | USD 7.25 | -0.16% |
|
Australia |
|
| 6 |
USD -2.43 M
|
Dec. 31, 2023 | USD 6.22 | 1.04% |
|
Australia |
|
| 7 |
USD -1.93 M
|
June 30, 2024 | USD 1.23 | 0.02% |
|
Australia |
|
| 8 |
USD -1.92 M
|
June 30, 2024 | USD 0.74 | 0.02% |
|
Australia |
|
| 9 |
USD -621.67 K
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
| 10 |
USD -336.05 K
|
June 30, 2024 | USD 2.34 | -4.83% |
|
Australia |
|
| 11 |
USD -331.00 K
|
June 30, 2024 | USD 1.84 | -3.30% |
|
Australia |
|
| 12 |
USD -277.00 K
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
|
| 13 |
USD -33.49 K
|
June 30, 2024 | NA |
|
Australia |
||
| 14 |
USD -3.82 K
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
| 15 |
USD -130.02
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
Frequently Asked Questions
-
Which Clinical Trials company in Australia has the highest Capital Expenditure ?
The Clinical Trials company in Australia with the highest Capital Expenditure is CSL Limited (ASX: CSL.AX) at USD -1.26 B.
-
Which Clinical Trials company in Australia has the lowest Capital Expenditure ?
The Clinical Trials company in Australia with the lowest Capital Expenditure is Immuron Limited (NasdaqCM: IMRN) at USD -130.02.
-
What are the top 10 Clinical Trials companies in Australia by Capital Expenditure ?
The top 10 Clinical Trials companies in Australia by Capital Expenditure are CSL Limited, Monash IVF Group Limited, Telix Pharmaceuticals Limited, Australian Clinical Labs Limited, Clinuvel Pharmaceuticals Limited, Anteris Technologies Ltd, PolyNovo Limited, Cogstate Limited, Immutep Limited and Clarity Pharmaceuticals Ltd.
-
What are the bottom 10 Clinical Trials companies in Australia by Capital Expenditure ?
The bottom 10 Clinical Trials companies in Australia by Capital Expenditure are Immuron Limited, Alterity Therapeutics Limited, Opthea Limited, Incannex Healthcare Limited, Mesoblast Limited, Clarity Pharmaceuticals Ltd, Immutep Limited, Cogstate Limited, PolyNovo Limited and Anteris Technologies Ltd.
